Browse By Assay Result Page of OvirusTdb

The total number record retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1251Vesicular stomatitis virusFusogenic strainRNARhabdoviridaeYes , expressing fusion proteinNoVSV in combination with cisplatin (0.1 microgram/ml)NoRichard wong labsquamous cell carcinoma cell lineSCCVII5.0E+4 cells per wellNAMTT assay0.01 MOI100% cancer cell killing after 72 hoursNoNoNA No responseNANANANA18043494
OV_1252Vesicular stomatitis viruswild typeRNARhabdoviridaeYesNoVSV in combination with cisplatin (0.1 microgram/ml)Virus expressing IL-12 geneGibcoHuman keratinocyteHuK5.0E+4 cells per wellNAMTT assay0.01 MOI20% cancer cell killing after 24 hoursNoNoNA No responseNANANANA18043494
OV_1253Vesicular stomatitis viruswild typeRNARhabdoviridaeYesNoVSV in combination with cisplatin (0.1 microgram/ml)Virus expressing IL-12 geneGibcoHuman keratinocyteHuK5.0E+4 cells per wellNAMTT assay0.01 MOI20% cancer cell killing after 48 hoursNoNoNA No responseNANANANA18043494
OV_1254Vesicular stomatitis viruswild typeRNARhabdoviridaeYesNoVSV in combination with cisplatin (0.1 microgram/ml)Virus expressing IL-12 geneGibcoHuman keratinocyteHuK5.0E+4 cells per wellNAMTT assay0.01 MOI20% cancer cell killing after 72 hoursNoNoNA No responseNANANANA18043494
OV_1255Vesicular stomatitis virusFusogenic strainRNARhabdoviridaeYes , expressing fusion proteinNoVSV in combination with cisplatin (0.1 microgram/ml)NoGibcoHuman keratinocyteHuK5.0E+4 cells per wellNAMTT assay0.01 MOINo cell killing after 24 hoursNoNoNA No responseNANANANA18043494
OV_1256Vesicular stomatitis virusFusogenic strainRNARhabdoviridaeYes , expressing fusion proteinNoVSV in combination with cisplatin (0.1 microgram/ml)NoGibcoHuman keratinocyteHuK5.0E+4 cells per wellNAMTT assay0.01 MOINo cell killing after 48 hoursNoNoNA No responseNANANANA18043494
OV_1257Vesicular stomatitis virusFusogenic strainRNARhabdoviridaeYes , expressing fusion proteinNoVSV in combination with cisplatin (0.1 microgram/ml)NoGibcoHuman keratinocyteHuK5.0E+4 cells per wellNAMTT assay0.01 MOINo cell killing after 72 hoursNoNoNA No responseNANANANA18043494
OV_1260AdenovirusAxdAdb-3DNAAdenoviridaeDouble mutated for E1A and E1B geneYesNoNoATCCProstate cancer cell lineDu1453.0E+3 cells per wellMTT assay30 MOISurviving cell number reached to 1000NoNoNA No responseNANANANA18063085
OV_1261AdenovirusAxdAdb-3DNAAdenoviridaeDouble mutated for E1A and E1B geneYesNoNoATCCProstate cancer cell linePC-33.0E+3 cells per wellMTT assay30 MOISurviving cell number reached to 10000NoNoNA No responseNANANANA18063085
OV_1262AdenovirusAxdAdb-3DNAAdenoviridaeDouble mutated for E1A and E1B geneYesNoNoATCCProstate cancer cell lineLNCaP3.0E+3 cells per wellMTT assay30 MOISurviving cell number reached to 1000NoNoNA No responseNANANANA18063085
OV_1354AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay0.01 MOI100% cell survivalNoNoNA No responseNANANANA18300357
OV_1355AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survivalNoNoNA No responseNANANANA18300357
OV_1356AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay1 MOI20% cell survivalNoNoNA No responseNANANANA18300357
OV_1357AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay10 MOI20% cell survivalNoNoNA No responseNANANANA18300357
OV_1358AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay100 MOIless than 20% cell survivalNoNoNA No responseNANANANA18300357
OV_1359AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay1000 MOIless than 20% cell survivalNoNoNA No responseNANANANA18300357
OV_1360AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNAMTT assay0.01 MOI100% cell survivalNoNoNA No responseNANANANA18300357
OV_1361AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNAMTT assay0.1 MOI30% cell survivalNoNoNA No responseNANANANA18300357
OV_1362AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNAMTT assay1 MOI100% cell killingNoNoNA No responseNANANANA18300357
OV_1363AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNAMTT assay10 MOI100% cell killingNoNoNA No responseNANANANA18300357
OV_1364AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNAMTT assay100 MOI100% cell killingNoNoNA No responseNANANANA18300357
OV_1365AdenovirusCNHK300DNAAdenoviridaeNoneYesNoNoATCCHepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNAMTT assay1000 MOI100% cell killingNoNoNA No responseNANANANA18300357
OV_1376AdenovirusZD55-Ki67DNAAdenoviridaeExpressing Ki67 ShRNAYesNoNoShanghai cell collectionHuman renal cacinoma cell line7861.0E+5 cells per wellNAMTT assay0.1 MOI85% cell survival after day 1NoNoNA No responseNAInduction of apoptosisNANA18690204
OV_1377AdenovirusZD55-Ki67DNAAdenoviridaeExpressing Ki67 ShRNAYesNoNoShanghai cell collectionHuman renal cacinoma cell line7861.0E+5 cells per wellNAMTT assay1 MOI75% cell survival after day 2NoNoNA No responseNAInduction of apoptosisNANA18690204
OV_1378AdenovirusZD55-Ki67DNAAdenoviridaeExpressing Ki67 ShRNAYesNoNoShanghai cell collectionHuman renal cacinoma cell line7861.0E+5 cells per wellNAMTT assay10 MOI60% cell survival after day 3NoNoNA No responseNAInduction of apoptosisNANA18690204
OV_1379AdenovirusZD55-Ki67DNAAdenoviridaeExpressing Ki67 ShRNAYesNoNoShanghai cell collectionHuman renal cacinoma cell line7861.0E+5 cells per wellNAMTT assay100 MOI40% cell survival after day 4NoNoNA No responseNAInduction of apoptosisNANA18690204
OV_1380AdenovirusZD55-Ki67DNAAdenoviridaeExpressing Ki67 ShRNAYesNoNoShanghai cell collectionHuman renal cacinoma cell line7861.0E+5 cells per wellNAMTT assay0.1 MOI100% cell survival after day 1NoNoNA No responseNAInduction of apoptosisNANA18690204
OV_1381AdenovirusZD55-Ki67DNAAdenoviridaeExpressing Ki67 ShRNAYesNoNoShanghai cell collectionHuman renal cacinoma cell lineACHN1.0E+5 cells per wellNAMTT assay1 MOI90% cell survival after day 2NoNoNA No responseNAInduction of apoptosisNANA18690204
OV_1382AdenovirusZD55-Ki67DNAAdenoviridaeExpressing Ki67 ShRNAYesNoNoShanghai cell collectionHuman renal cacinoma cell lineACHN1.0E+5 cells per wellNAMTT assay10 MOI60% cell survival after day 3NoNoNA No responseNAInduction of apoptosisNANA18690204
OV_1383AdenovirusZD55-Ki67DNAAdenoviridaeExpressing Ki67 ShRNAYesNoNoShanghai cell collectionHuman renal cacinoma cell lineACHN1.0E+5 cells per wellNAMTT assay100 MOI20% cell survival after day 4NoNoNA No responseNAInduction of apoptosisNANA18690204
OV_1397AdenovirusZD55-hTERTDNAAdenoviridaeDeletion of E1B gene and addition of shRNA expressing hTERTYesNoNoShanghai cell collectionRenal cancer cell lineKetr-31.0E+5 cells per wellNAMTT assay10 MOI90% cell survival after day 1NoNoNA No responseNAInduction of apoptosisNANA19029834
OV_1398AdenovirusZD55-hTERTDNAAdenoviridaeDeletion of E1B gene and addition of shRNA expressing hTERTYesNoNoShanghai cell collectionRenal cancer cell lineKetr-31.0E+5 cells per wellNAMTT assay10 MOI50% cell survival after day 2NoNoNA No responseNAInduction of apoptosisNANA19029834
OV_1399AdenovirusZD55-hTERTDNAAdenoviridaeDeletion of E1B gene and addition of shRNA expressing hTERTYesNoNoShanghai cell collectionRenal cancer cell lineKetr-31.0E+5 cells per wellNAMTT assay10 MOI45% cell survival after day 3NoNoNA No responseNAInduction of apoptosisNANA19029834
OV_1400AdenovirusZD55-hTERTDNAAdenoviridaeDeletion of E1B gene and addition of shRNA expressing hTERTYesNoNoShanghai cell collectionRenal cancer cell lineKetr-31.0E+5 cells per wellNAMTT assay10 MOI30% cell survival after day 4NoNoNA No responseNAInduction of apoptosisNANA19029834
OV_1401AdenovirusZD55-hTERTDNAAdenoviridaeDeletion of E1B gene and addition of shRNA expressing hTERTYesNoNoShanghai cell collectionRenal cancer cell lineKetr-31.0E+5 cells per wellNAMTT assay0.1 MOI90% cell survivalNoNoNA No responseNAInduction of apoptosisNANA19029834
OV_1402AdenovirusZD55-hTERTDNAAdenoviridaeDeletion of E1B gene and addition of shRNA expressing hTERTYesNoNoShanghai cell collectionRenal cancer cell lineKetr-31.0E+5 cells per wellNAMTT assay1 MOI60% cell survivalNoNoNA No responseNAInduction of apoptosisNANA19029834
OV_1403AdenovirusZD55-hTERTDNAAdenoviridaeDeletion of E1B gene and addition of shRNA expressing hTERTYesNoNoShanghai cell collectionRenal cancer cell lineKetr-31.0E+5 cells per wellNAMTT assay10 MOI30% cell survivalNoNoNA No responseNAInduction of apoptosisNANA19029834
OV_1404AdenovirusZD55-hTERTDNAAdenoviridaeDeletion of E1B gene and addition of shRNA expressing hTERTYesNoNoShanghai cell collectionRenal cancer cell lineKetr-31.0E+5 cells per wellNAMTT assay100 MOI20% cell survivalNoNoNA No responseNAInduction of apoptosisNANA19029834
OV_1406ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with norfloxacin (12.5 microgram/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.5 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1407ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with norfloxacin (12.5 microgram/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI35% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1408ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with norfloxacin (25 microgram/ml)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-3NANAMTT assay0.5 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1409ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with norfloxacin (25 microgram/ml)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-3NANAMTT assay1 MOI30% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1410ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (6.25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1411ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (6.25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1412ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (6.25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI60% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1413ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1414ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1415ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI65% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1416ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1417ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1418ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI65% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1419ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI50% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1420ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI50% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1421ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI45% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1422ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI30% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1423ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI30% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1424ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI20% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1425ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI42% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1426ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI42% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1427ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (12.5pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI40% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1428ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI20% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1429ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI20% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1430ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (25pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1431ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1432ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1433ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (50pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1434ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay0.1 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1435ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay1 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1436ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with reservatol (100pg/ml)NoATCCHuman pancreatic adenocarcinoma cell linePANC-1NANAMTT assay10 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1667Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1668Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1669Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1670Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1671Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1672Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1673Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1674Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI80% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1675Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI80% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1676Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI70% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1677Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1678Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1679Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1680Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1681Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineA-4982.0E+4 cells per wellNAMTT assay0.1 MOI50% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1682Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1683Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1684Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1685Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1686Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1687Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1688Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1689Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI80% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1690Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI80% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1691Measles virusMV-Edm strainRNAParamyxoviridaeMV-P virus , addition of P geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI75% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1692Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1693Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1694Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survival after 72 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1695Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survival after 96 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1696Measles virusMV-Edm strainRNAParamyxoviridaeMV-NPL virus , addition of P, N and L geneYesNoNoNAHuman renal cell carcinoma cell lineOS-RC-22.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survival after 120 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938
OV_1697Measles virusMV-Edm strainRNAParamyxoviridaeMV-Etag virusYesNoNoNAHuman renal cell carcinoma cell lineT52.0E+4 cells per wellNAMTT assay0.1 MOI90% cell survival after 24 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellsInduce expression of IFN-gamma, an antiviral proteinNA20051938